You are viewing United States

FloraGLO® Lutein for Brain Health

From protecting the developing infant brain to supporting cognitive function in adults, lutein is supported by a growing body of research as an important nutrient for brain function throughout all stages of life. No other lutein is backed by more research on brain health than FloraGLO® Lutein. Researchers and leading vitamin manufacturers all over the world rely on the quality and safety profile of FloraGLO and its proven efficacy. 

FloraGLO Lutein for the Developing Infant and Child

Currently, FloraGLO is the only lutein brand used in 15 publications of interventional studies investigating the effects of lutein for infants. FloraGLO is also the only lutein brand that is Generally Recognized As Safe (GRAS) for use in term and pre-term infant formula. Therefore, FloraGLO is the NO. 1 choice as a source of lutein for prenatal, infant and pediatric products for neural development and protection during infancy and childhood. 

  • Clinically proven safe for use in infant nutrition
  • The ONLY lutein brand GRAS for infant formula4

FloraGLO Benefits to the Brain


FloraGLO® Lutein: So Much More Than An "Eye Vitamin"

Supporting Eye & Brain Health

Advancing Brain Health

Want to learn more about FloraGLO Lutein?

If you're interested in formulating with FloraGLO Lutein, fill out the form below and a Kemin representative will be in touch shortly.

Recommended use: a dose of = 10 mg FloraGLO® Lutein and 2 mg OPTISHARP™ Natural Zeaxanthin is considered efficacious.

These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region specific information should also be considered when labeling or advertising to final consumers.

This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region specific regulations should be considered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.


  1. PubMed, 2018.
  2. Based on the results of the IQVIA IMS National Disease and Therapeutic Index (NDTI) syndicated report among physicians who recommend a dietary supplement with lutein for eye health through between June 1, 2017 to May 31, 2018.
  3. Roberts, Richard. “Methods of Treating Ocular Disorders.” Kemin Industries, Inc., assignee. Patent US9226940 B2. 5 Jan. 2016.
  4. U.S. Food & Drug Administration, 2004. GRAS Notice Inventory, GRN No. 140, 221 and 390.
  5. TL-10-00183, Human Clinical Trials with FloraGLO Lutein (KHTL-017-083)